These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 12110776)

  • 21. Differential diagnosis of hyperthyroidism: Doppler sonographic quantification of thyroid blood flow distinguishes between Graves' disease and diffuse toxic goiter.
    Saleh A; Cohnen M; Fürst G; Godehardt E; Mödder U; Feldkamp J
    Exp Clin Endocrinol Diabetes; 2002 Jan; 110(1):32-6. PubMed ID: 11835123
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The clinical and laboratory findings in Graves' multinodular type disease].
    Grammaticos P; Vasiliou O; Papanastasiou E; Gerasimou G; Balaris V; Alexandris R; Liaros G; Dedousi E
    Hell J Nucl Med; 2006; 9(1):53-9. PubMed ID: 16617399
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased plasma levels of free tissue factor pathway inhibitor in patients with Graves' disease.
    Morishita E; Hashimoto T; Asakura H; Saito M; Yamazaki M; Aoshima K; Yoshida T; Kato H; Matsuda T
    Thromb Haemost; 1998 May; 79(5):919-23. PubMed ID: 9609221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Plasma free triiodothyronine response to thyrotropin-releasing hormone to predict the remission of Graves' disease treated with antithyroid drugs.
    Notsu K; Oka N; Masaki Y; Furuya H; Kato Y
    J Clin Endocrinol Metab; 1991 Aug; 73(2):396-400. PubMed ID: 1713218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic Utility of Mean Peak Systolic Velocity of Superior Thyroid Artery in Differentiating Graves' Disease from Thyroiditis.
    Sarangi PK; Parida S; Mangaraj S; Mohanty BK; Mohanty J; Swain BM
    Indian J Radiol Imaging; 2021 Apr; 31(2):311-317. PubMed ID: 34556913
    [No Abstract]   [Full Text] [Related]  

  • 26. [Observation on therapeutic effect of picking therapy on Graves' disease].
    Li GL; Zhou ZX; Li JM
    Zhongguo Zhen Jiu; 2006 Nov; 26(11):769-71. PubMed ID: 17165495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Analysis of serum levels of ghrelin and obestatin in children and adolescents with autoimmune thyroid diseases].
    Sawicka B; Bossowski A; Urban M; Szalecki M; Wysocka J; Koput A; Zelazowska-Rutkowska B; Tobolczyk J; Skrzydło M; Rogowski F; Luba M
    Pediatr Endocrinol Diabetes Metab; 2009; 15(1):20-7. PubMed ID: 19454185
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Frequency and characteristics of TBII-seronegative patients in a population with untreated Graves' hyperthyroidism: a prospective study.
    Vos XG; Smit N; Endert E; Tijssen JG; Wiersinga WM
    Clin Endocrinol (Oxf); 2008 Aug; 69(2):311-7. PubMed ID: 18208575
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Relationship of thyroid states and serum thrombomodulin (TM) levels in patients with Graves' disease: TM, a possible new marker of the peripheral activity of thyroid hormones.
    Morikawa Y; Morikawa A; Makino I
    J Clin Endocrinol Metab; 1993 Mar; 76(3):609-14. PubMed ID: 7680353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum immunoglobulin E and soluble CD23 in patients with Graves' disease.
    Sayinalp S; Akalin S; Sayinalp N; Erbaş T; Bayraktar M; Ozcebe OI; Dündar S; Kirazli S
    Horm Metab Res; 1996 Mar; 28(3):133-7. PubMed ID: 8926012
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T3-release from autonomously functioning thyroid nodules in vitro.
    Poertl S; Kirner J; Saller B; Mann K; Hoermann R
    Exp Clin Endocrinol Diabetes; 1998; 106(6):489-93. PubMed ID: 10079030
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease.
    Wan Nazaimoon WM; Khalid BA
    Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [The characteristics of two-dimensional and color Doppler ultrasonography in Graves' disease].
    Li J; Zhang J; Bai Y
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1994 Jun; 16(3):170-4. PubMed ID: 7805159
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Study of serum thrombomodulin(TM) levels in patients with hyper- or hypo- thyroidism].
    Soma M; Maeda Y; Matsuura R; Sasaki I; Kasakura S; Saeki Y; Ikekubo K; Ishihara T; Kurahachi H; Sasaki S; Tagami T; Nakao K
    Rinsho Byori; 1997 Jan; 45(1):77-81. PubMed ID: 9022347
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy.
    Prummel MF; Wiersinga WM; Mourits MP; Koornneef L; Berghout A; van der Gaag R
    Arch Intern Med; 1990 May; 150(5):1098-101. PubMed ID: 1691908
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Duplex sonography in functional thyroid diagnosis].
    Schweiger U; Hosten N; Cordes M; Lemke AJ; Rümpler W; Meng W; Felix R
    Rofo; 1996 Feb; 164(2):114-8. PubMed ID: 8679972
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Radioiodine therapy in Graves' disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy.
    Sabri O; Zimny M; Schreckenberger M; Reinartz P; Ostwald E; Buell U
    Thyroid; 1999 Dec; 9(12):1181-8. PubMed ID: 10646656
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Age and stress as determinants of the severity of hyperthyroidism caused by Graves' disease in newly diagnosed patients.
    Vos XG; Smit N; Endert E; Brosschot JF; Tijssen JG; Wiersinga WM
    Eur J Endocrinol; 2009 Feb; 160(2):193-9. PubMed ID: 18974230
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Arterial distensibility, intima media thickness and pulse wave velocity after renal transplantation and in dialysis normotensive patients.
    Posadzy-Malaczyñska A; Kosch M; Hausberg M; Rahn KH; Stanisic G; Malaczynski P; Gluszek J; Tykarski A
    Int Angiol; 2005 Mar; 24(1):89-94. PubMed ID: 15877005
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Role of Doppler color ultrasonography and of flowmetric analysis in the diagnosis and follow-up of Grave's disease].
    Sponza M; Fabris B; Bertolotto M; Ricci C; Armini L
    Radiol Med; 1997 Apr; 93(4):405-9. PubMed ID: 9244919
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.